N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Benzamide, 98%, 100mg

Antimony(III) chloride, min. 99%, pa, ACS, 100 g, plastic packaging.

2-Benzyl-2,8-diazaspiro[4.5]decane, 95.0%, 100mg

3-Pyrazol-1-yl-butyric acid, 95.0%, 250mg

2-Amino-5,7-difluorobenzothiazole, 97.0%, 250mg

6,7-Dihydro-5H-cyclopenta[b]pyridin-7-ol, 95.0%, 10g

3-Dodecyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene>95.0%(GC)5g

2,2,4-Trimethyl-1,3-dioxolane, 98%, 5g

4-Bromophenylhydrazine hydrochloride, 98.0%, 25g

(1S,2S)-N1,N1,N2,N2-Tetramethylcyclohexane-1,2-diamine, 97%, 10g

FMOC-N-METHYL-L-2-AMINOBUTYRIC ACID, 95.0%, 5g

tert-Butyl 2-(6-bromo-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoate, 98%, 1g

5-Bromo-2,3-dimethyl-2H-indazole, 95.0%, 250mg